Moneycontrol PRO
HomeNewsPenicillin

Penicillin

Jump to
  • Orchid Chemicals up 5% as Q3 loss shrinks to Rs 53.90 cr

    During the quarter, its total operating income jumped 18.5 percent to Rs 371.60 crore from Rs 313.53 crore in the same period last fiscal.

  • Can we avoid an antibiotic apocalypse?

    Can we avoid an antibiotic apocalypse?

    Since drugs such as penicillin are so widely used - if not abused - the bacteria they fight are now mutating and becoming resistant.

  • Aurobindo Pharma gets US FDA nod for Nafcillin injections

    Aurobindo Pharma gets US FDA nod for Nafcillin injections

    Aurobindo Pharma on Thursday said it has received final approval from US Food and Drugs Administration to manufacture and market Nafcillin for Injection packaged in 1g and 2g vials and Nafcillin for Injection in 10g/vial pharmacy bulk package.

  • Hospira deal to be Rs 7-8 EPS accretive: Orchid Chemicals

    Hospira deal to be Rs 7-8 EPS accretive: Orchid Chemicals

    Shares of Orchid Chemicals were on the rise after the pharmaceutical company sold its penicillin and penem business to US-based Hospira Inc for USD 200 million.

  • A miracle drug that can cure any viral infection developed

    A miracle drug that can cure any viral infection developed

    In what might be the greatest medical discovery since penicillin, scientists have developed a broad-spectrum drug which they claim can cure everything -- from the common cold to HIV to almost any other virus one can think of.

  • Dr Reddys completes acquisition of US penicillin facility

    Dr Reddys completes acquisition of US penicillin facility

    Dr Reddys Laboratories touched an intraday high of Rs 1,644.65 and an intraday low of Rs 1,616. At 11:12 hrs the share was quoting at Rs 1,632.50, up Rs 34.10, or 2.13%. The company has announced completion of the acquisition of US penicillin facility and products from GlaxoSmithKline.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347